Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valeo Pharma Inc T.VPH.DB


Primary Symbol: T.VPH Alternate Symbol(s):  VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Recent & Breaking News (TSX:VPH)

Specialty Pharma, Telemedicine, Mobile Shopping & E-Wallets, Augmented Reality & Virtual Tradeshows. CEO's of NEXT SUPER STOCK presenters, Weyland Tech, CloudMD, NexTech AR, and Valeo Pharma Addressing Billion Dollar Market Opportunities

GlobeNewswire July 31, 2020

Valeo Pharma Applies for Listing on the U.S. OTCQB Market

Canada NewsWire July 29, 2020

Valeo Pharma to Present at Wall Street Reporter's Livestream Conference on July 29, 2020

PR Newswire July 28, 2020

Valeo Pharma Receives Approval from Health Canada for the Transfer of Commercial Rights to Ametop(TM)

Canada NewsWire July 13, 2020

Valeo Pharma Closes $1.7 Million Oversubscribed Private Placement

Canada NewsWire July 10, 2020

Valeo Pharma Reports its 2020 Second Quarter Results and Initiates $1 Million Debenture Private Placement

Canada NewsWire July 2, 2020

Valeo Pharma Receives Approval from Health Canada for the Transfer of Commercial Rights to Yondelis® in Canada

Canada NewsWire June 8, 2020

Valeo Pharma Licenses Canadian Rights to Ametop(TM) Gel from Alliance Pharma

Canada NewsWire April 28, 2020

Valeo Pharma Reports its 2020 First Quarter Results

Canada NewsWire March 27, 2020

Valeo Pharma Comments on World Health Organization's Best Practices Recommending Use of Low Molecular Weight Heparin to Help Prevent Complications Related to COVID-19 Infections

Canada NewsWire March 17, 2020

Valeo Pharma Reports 2019 Financial Results and Closing of $2.1 Million Private Placement

Canada NewsWire February 28, 2020

Valeo Pharma's Onstryv® Receives Positive Recommendation for Public Reimbursement in Quebec

Canada NewsWire February 6, 2020

Valeo Pharma Signs Licensing Agreement with Pharmamar to Commercialize Yondelis® in Canada

Canada NewsWire January 21, 2020

CORRECTION FROM SOURCE - Valeo Pharma Announces Change of Auditor

Canada NewsWire November 22, 2019

Valeo Pharma Announces Filing of a New Drug Submission for Low Molecular Weight Heparin in Canada

Canada NewsWire November 14, 2019

Valeo Pharma Announces $4.0 Million Non-Brokered Private Placement of Convertible Debentures

Canada NewsWire November 6, 2019

Valeo Pharma Announces Change of Auditor

Canada NewsWire October 30, 2019

Valeo Pharma Appoints Michel Trudeau to its Board of Directors

Canada NewsWire September 26, 2019

Valeo Pharma reports its third quarter 2019 financial results

Canada NewsWire September 25, 2019

Valeo Pharma Warrants To Begin Trading On CSE Under The Symbol VPH.WT

Canada NewsWire July 29, 2019